Powering cell-based medicines

Drew Titmarsh is a trained chemical and biological engineer who designs and builds technology to understand the processes that drive the regeneration of human cells and tissue. He is the core developer of the microbioreactor array technology which is the workhorse platform of Scaled Biolabs. He has coordinated multidisciplinary projects at the Australian Institute for Bioengineering and Nanotechnogy (Brisbane, Australia), and the Institute for Medical Biology, A*STAR (Singapore) in the areas of tissue engineering and regenerative medicine.

Brendan Griffen has lead several large, data-driven projects in the fields of computational cosmology, astrophysics and theoretical physics at leading institutes across the USA, UK, Germany and Australia. Having completed his postdoctoral research at MIT's Kavli Institute For Astrophysics & Space Research, he now builds the analytical backend behind Scaled Biolabs' high-throughput wet lab platform employing tools such as statistical methods, control systems, optimization, computer vision and machine learning.

Professor Justin Cooper-White is a global leader in using engineering to solve problems in biology. In addition to holding the position of The Australian Institute of Bioengineering & Nanotechnology Group Leader, Professor Cooper-White is Director of the Australian National Fabrication Facility-Queensland Node and is one of only 13 CSIRO Office of the Chief Executive Science Leaders in Australia. He is a past President of both the Australasian Society for Biomaterials and Tissue Engineering and the Australian Society of Rheology and has previously served as an Associate Dean at the UQ Faculty of Engineering, Architecture and Information Technology.